DEFUSE 3 was a multicenter, randomized trial that compared thrombectomy with medical management for the treatment of ischemic stroke due to an anterior circulation large vessel occlusion in patients Background and Purpose-Thrombectomy in late time windows leads to improved outcomes in patients with ischemic stroke due to large vessel occlusion. We determined whether patients with rapid neurological improvement (RNI) 24 hours after thrombectomy were more likely to have a favorable clinical outcome in the DEFUSE 3 study (Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3). Methods-All patients who underwent thrombectomy in DEFUSE 3 were included. RNI was defined as a reduction of ≥8 on the National Institutes of Health Stroke Scale or National Institutes of Health Stroke Scale zero to one 24 hours after thrombectomy. Clinical outcomes were assessed by an ordinal analysis modified Rankin Scale score and a dichotomous analysis for 90-day independence (modified Rankin Scale score, 0-2). Results-Ninety-one patients in DEFUSE 3 underwent thrombectomy with follow-up data; 31 patients (34%) experienced RNI (RNI+) after thrombectomy and 60 patients (66%) did not (RNI− 
ndovascular thrombectomy is an effective therapy for acute ischemic stroke caused by occlusions of the internal carotid artery or first or second segment of the middle cerebral artery. [1] [2] [3] [4] [5] [6] [7] Some patients experience rapid neurological improvement (RNI) after stroke treatment by thrombectomy or intravenous thrombolysis, which has emerged as an early indicator of a favorable long-term clinical outcome. [8] [9] [10] [11] [12] [13] [14] However, RNI has only been described for the treatment of patients between zero and 6 hours after last known well.
The DEFUSE 3 study (Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3) demonstrated the effectiveness of thrombectomy in patients who were treated 6 to 16 hours after last seen normal with a target mismatch profile on perfusion imaging. 7 The purpose of this study was to determine the frequency of RNI in patients undergoing thrombectomy in late time windows and whether RNI is an early predictor of a favorable clinical outcome 90 days after treatment.
who were last known to be normal 6 to 16 hours before enrollment. The study protocol 15 and primary article 7 have been published previously. Patients were selected for enrollment after computed tomography (CT) or magnetic resonance imaging studies with perfusion imaging; enrolled patients had a target mismatch between the core infarction and the salvageable penumbra. 15 This is a post hoc analysis of all DEFUSE 3 patients who underwent thrombectomy. All included patients or their next of kin provided informed consent for inclusion in the DEFUSE 3, and this study was approval by our institutional review board. The DEFUSE 3 trial registration is found at https://www.clinicaltrials.gov.
Clinical Definitions and Outcomes
RNI was defined as a reduction of ≥8 on the National Institutes of Health Stroke Scale (NIHSS) or NIHSS zero to one 24 hours after thrombectomy. 12, 13 All imaging outcomes were determined by the DEFUSE 3 core laboratory in a blinded manner. 7, 15 Collaterals were rated by CT angiography with the binary modified Tan collateral scale 16, 17 ; good collaterals were defined as those that filled >50% of the vascular territory distal of the occluded middle cerebral artery of internal carotid artery, and poor collaterals were those that filled ≤50% of the territory distal to the arterial occlusion. Postthrombectomy angiographic revascularization was quantified using the Thrombolysis in Cerebral Infarction (TICI) score, and successful revascularization was defined as TICI 2b or 3.
18 Pre-and post-thrombectomy core and penumbra volumes were quantified by automated software (RAPID; iSchemaView, Menlo Park, CA). 15 Reperfusion was assessed on 24-hour magnetic resonance or CT perfusion studies as described previously. 15 Infarction growth was determined by subtracting the baseline core infarction volume from the 24-hour core infarction volume by the DEFUSE 3 core laboratory. Favorable discharge location was defined as patient discharge to home, acute rehabilitation unit, home with home care, or subacute rehabilitation. Unfavorable discharge location was defined as discharge to hospice, skilled nursing facility, acute care facility, or death. Hospital length of stay was reported ordinally and considered in a binary manner (≤4 days [favorable] versus >4 days [unfavorable] for the regression analysis). Clinical outcomes were assessed 90 days after treatment using the ordinal modified Rankin Scale (mRS). Favorable clinical outcome was defined as mRS zero to 2 at 90 days.
Statistical Analysis
Patient demographics, clinical variables, and neuroimaging data were compared between patients with RNI (RNI+) and those without RNI (RNI−) using the χ 2 and Wilcoxon rank-sum tests. The association between RNI and neurological outcome was assessed using a logistic regression model that was fitted to the primary outcome and ordinal logistic regression models for the secondary outcomes. The model was adjusted for additional covariates that were independently associated with the primary outcome: patient age, presentation NIHSS and serum glucose at enrollment, and time from last known normal to randomization. For the ordinal logistic regression models, the proportional odds assumption had to be met (P>0.05) before further analysis. To test the hypothesis that RNI+ patients were more likely to achieve a favorable clinical outcome, we derived odds ratios (ORs) for more favorable 90-day functional outcome stratified by RNI. Alpha was set at the 0.05 level, and all reported results are 2 sided. Statistical analysis was done using SAS 9.4.
Results
Changes in NIHSS after enrollment were first compared between patients treated by medical therapy versus thrombectomy ( Figure) . There was no difference in median presentation NIHSS ( 
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Thrombectomy patients were then dichotomized into RNI+ (31 patients; 34%) and RNI− (60 patients; 65%). A single patient who experienced a large reperfusion hemorrhage and died without a 24-hour NIHSS being recorded was excluded from the analysis. There were no differences in age, sex, or medical comorbidities between RNI+ and RNI− patients (Table 1 ). Median presentation NIHSS was similar between RNI+ (17 [IQR, [13] [14] [15] [16] [17] [18] [19] [20] [21] ) and RNI− (15.5 [IQR, 9.5-20]; P=0.2), and there were no differences in the frequency of intravenous tPA administration, right hemisphere stroke, frequency of internal carotid artery occlusion, presentation ischemic core volume, perfusion lesion volume, Alberta Stroke Program Early CT Score, or time from last seen normal to qualifying imaging between these groups (Table 1) . There were no differences in the frequency of good collaterals on the baseline CT angiography between RNI+ (79%; 19 of 24) and RNI− (73%; 29 of 40; P=0.55) groups.
Thrombectomy treatment details are presented in Table 2 . Final TICI scores were more favorable in the RNI+ compared with the RNI− patients (P=0.04). Revascularization (TICI 2b/3) on cerebral angiography was achieved in 84% of RNI+ and 72% of RNI− patients, but these differences were not significant (P=0.2). After thrombectomy, median NIHSS at 24 hours was lower in RNI+ patients (5 Table 2 ). There was a nonsignificant trend toward reduced mortality in RNI+ patients (3% versus 18% in RNI−; P=0.05).
In the primary outcome and secondary outcome regression analysis ( 
Discussion
We found that patients who experience RNI 24 hours after thrombectomy in late time windows are more likely to achieve a favorable ordinal mRS score and a favorable clinical outcome (mRS, 0-2) at 90 days. Prior studies have identified RNI, which is also termed early neurological improvement or dramatic neurological improvement, as a marker of excellent long-term clinical outcomes after intravenous tPA administration [12] [13] [14] 19 or endovascular stroke treatment [8] [9] [10] within zero to 6 hours of symptom onset. In the DEFUSE 3 study, RNI occurred in 34% of patients who underwent thrombectomy, which is similar to the reported 26% to 42% frequency of RNI in early-time-window studies. [9] [10] [11] This study is the first to identify RNI as an important early predictor of excellent long-term outcomes following thrombectomy in extended time windows.
In early-time-window studies, RNI has been associated with good pial collaterals, 10,11 a small core infarct volume, 10, 11 and shorter time to reperfusion. 10, 11 By contrast, RNI was not associated with good collaterals, core infarction volume at presentation, or time to reperfusion in the DEFUSE 3 study. We hypothesize that the selection of patients with a target mismatch between core infarction and penumbra in DEFUSE 3 may account for these differences.
It is possible that the modern thrombectomy techniques (stent retrievers and aspiration thrombectomy) used in DEFUSE 3 might influence the likelihood of RNI. We identified a significant difference in TICI scores after thrombectomy between RNI+ and RNI− patients, and there was a nonsignificant trend toward greater revascularization rates in RNI+ patients (84% versus 72%). In addition, perfect revascularization (TICI 3) was achieved in 35% of RNI+ patients compared with only 12% in RNI− patients. These findings also likely explain the higher percentage of cerebral reperfusion follow-up magnetic resonance or CT perfusion studies in RNI+ patients (93% versus 73%). These differences likely account for the larger core infarct volumes and greater degree of core infarct growth at 24 hours post-randomization in RNI− patients. Our observation that RNI was associated with a shorter hospital stay and favorable discharge location may have additional prognostic importance and implications for discharge planning following thrombectomy. RNI may also be a marker for decreased costs associated with stroke care, although we did not address cost issues in this study.
When we considered the entire DEFUSE 3 cohort, we found thrombectomy to be associated with substantial NIHSS improvement at 24 hours, discharge, 30 days, and 90 days. Interestingly, the largest difference in NIHSS between the endovascular and medical treatment groups was at 30 days (11.5 points on the NIHSS). However, patients treated by thrombectomy had NIHSS that were at least 7 points lower at all time points examined, which is consistent with the large treatment effect of thrombectomy.
This study is limited by its small sample size for analysis.
Conclusions
RNI following thrombectomy correlates with favorable clinical and radiographic outcomes and a reduced hospital length of stay. RNI was an early favorable prognostic sign following late-window thrombectomy in the DEFUSE 3 cohort. Adjusted for presentation NIHSS, age, blood glucose, and time to randomization. mRS indicates modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; OR, odds ratio; and RNI, rapid neurological improvement.
